Changes in the prevalence of hepatitis B and C viral infections in Sindh province, Pakistan: Findings from two sero-surveys in 2007 and 2019

IF 2.5 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Journal of Viral Hepatitis Pub Date : 2024-07-26 DOI:10.1111/jvh.13986
Tesfa Sewunet Alamneh, Josephine G. Walker, Aaron G. Lim, Ejaz Alam, Saeed Hamid, Graham R. Foster, Naheed Choudhry, M. Azim Ansari, Huma Qureshi, Peter Vickerman
{"title":"Changes in the prevalence of hepatitis B and C viral infections in Sindh province, Pakistan: Findings from two sero-surveys in 2007 and 2019","authors":"Tesfa Sewunet Alamneh,&nbsp;Josephine G. Walker,&nbsp;Aaron G. Lim,&nbsp;Ejaz Alam,&nbsp;Saeed Hamid,&nbsp;Graham R. Foster,&nbsp;Naheed Choudhry,&nbsp;M. Azim Ansari,&nbsp;Huma Qureshi,&nbsp;Peter Vickerman","doi":"10.1111/jvh.13986","DOIUrl":null,"url":null,"abstract":"<p>Pakistan harbours a large burden of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. We utilised repeat sero-surveys to assess progress achieved towards hepatitis elimination in Pakistan. Multilevel logistic regression evaluated the change in HBV infection (HBV surface antigen (HBsAg)-positive) prevalence and HCV exposure (HCV antibody (HCV-Ab)-positive) prevalence between two sero-surveys from 2007 and 2019 for Sindh province and associated risk factors. Adjusted odds ratios (aORs) were estimated and population-attributable fractions (PAF) for modifiable risk factors for HCV exposure. The 2007 and 2019 surveys included 8855 and 6672 individuals. HBsAg prevalence decreased from 2.6% (95% confidence intervals (95% CI): 2.2–2.9) in 2007 to 1.1% (95% CI: 0.8–1.3) in 2019, while HCV-Ab prevalence increased from 5.1% (95% CI: 4.6%–5.5%) to 6.2% (95% CI: 5.6%–6.8%). The age and gender-adjusted HBsAg prevalence decreased by 80% (aOR = 0.2, 95% CI: 0.1–0.4) among children and 60% (aOR = 0.4, 95% CI: 0.3–0.6) among adults over 2007–2019, while HCV-Ab prevalence decreased by 60% (aOR = 0.4, 95%CI:0.2–0.7) in children and increased by 40% (aOR = 1.4, 95% CI: 1.2–1.7) in adults. HCV-Ab prevalence was lower in adults with secondary (aOR = 0.6, 95% CI: 0.5–0.8) and higher (aOR = 0.5, 95%CI:0.3–0.8) education compared to illiterates and higher among adults reporting blood transfusion (aOR = 1.7, 95% CI: 1.2–2.4), family history of hepatitis (aOR = 2.5, 95% CI: 1.9–3.3), past year medical injection (aOR = 2.1, 95% CI: 1.6–2.7), being tattooed (aOR = 1.4, 95% CI: 1.0–1.9) and shaved by traditional barber (aOR = 1.2, 95% CI: 1.0–1.5). Modifiable risk factors accounted for 45% of HCV exposure, with medical injection(s) accounting for 38% (95%CI,25.7–48.4%). Overall HCV has increased over 2007–2019 in Sindh province, while HBV prevalence has decreased. Medical injections should be an important focus of prevention activities.</p>","PeriodicalId":17762,"journal":{"name":"Journal of Viral Hepatitis","volume":"31 11","pages":"645-656"},"PeriodicalIF":2.5000,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jvh.13986","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Viral Hepatitis","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jvh.13986","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Pakistan harbours a large burden of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. We utilised repeat sero-surveys to assess progress achieved towards hepatitis elimination in Pakistan. Multilevel logistic regression evaluated the change in HBV infection (HBV surface antigen (HBsAg)-positive) prevalence and HCV exposure (HCV antibody (HCV-Ab)-positive) prevalence between two sero-surveys from 2007 and 2019 for Sindh province and associated risk factors. Adjusted odds ratios (aORs) were estimated and population-attributable fractions (PAF) for modifiable risk factors for HCV exposure. The 2007 and 2019 surveys included 8855 and 6672 individuals. HBsAg prevalence decreased from 2.6% (95% confidence intervals (95% CI): 2.2–2.9) in 2007 to 1.1% (95% CI: 0.8–1.3) in 2019, while HCV-Ab prevalence increased from 5.1% (95% CI: 4.6%–5.5%) to 6.2% (95% CI: 5.6%–6.8%). The age and gender-adjusted HBsAg prevalence decreased by 80% (aOR = 0.2, 95% CI: 0.1–0.4) among children and 60% (aOR = 0.4, 95% CI: 0.3–0.6) among adults over 2007–2019, while HCV-Ab prevalence decreased by 60% (aOR = 0.4, 95%CI:0.2–0.7) in children and increased by 40% (aOR = 1.4, 95% CI: 1.2–1.7) in adults. HCV-Ab prevalence was lower in adults with secondary (aOR = 0.6, 95% CI: 0.5–0.8) and higher (aOR = 0.5, 95%CI:0.3–0.8) education compared to illiterates and higher among adults reporting blood transfusion (aOR = 1.7, 95% CI: 1.2–2.4), family history of hepatitis (aOR = 2.5, 95% CI: 1.9–3.3), past year medical injection (aOR = 2.1, 95% CI: 1.6–2.7), being tattooed (aOR = 1.4, 95% CI: 1.0–1.9) and shaved by traditional barber (aOR = 1.2, 95% CI: 1.0–1.5). Modifiable risk factors accounted for 45% of HCV exposure, with medical injection(s) accounting for 38% (95%CI,25.7–48.4%). Overall HCV has increased over 2007–2019 in Sindh province, while HBV prevalence has decreased. Medical injections should be an important focus of prevention activities.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
巴基斯坦信德省乙型肝炎和丙型肝炎病毒感染流行率的变化:2007年和2019年两次血清调查的结果。
巴基斯坦的乙型肝炎病毒 (HBV) 和丙型肝炎病毒 (HCV) 感染率很高。我们利用重复血清调查来评估巴基斯坦在消除肝炎方面取得的进展。多层次逻辑回归评估了信德省 2007 年至 2019 年两次血清调查之间 HBV 感染(HBV 表面抗原 (HBsAg) 阳性)流行率和 HCV 暴露(HCV 抗体 (HCV-Ab) 阳性)流行率的变化以及相关风险因素。估算了调整后的几率比(aORs),并估算了HCV暴露的可改变风险因素的人口可归因分数(PAF)。2007 年和 2019 年的调查分别包括 8855 人和 6672 人。HBsAg 患病率从 2007 年的 2.6%(95% 置信区间 (95%CI):2.2-2.9)下降到 2019 年的 1.1%(95% CI:0.8-1.3),而 HCV-Ab 患病率则从 5.1%(95% CI:4.6%-5.5%)上升到 6.2%(95% CI:5.6%-6.8%)。在 2007-2019 年期间,经年龄和性别调整的 HBsAg 患病率在儿童中下降了 80%(aOR = 0.2,95%CI:0.1-0.4),在成人中下降了 60%(aOR = 0.4,95%CI:0.3-0.6),而 HCV-Ab 患病率在儿童中下降了 60%(aOR = 0.4,95%CI:0.2-0.7),在成人中上升了 40%(aOR = 1.4,95%CI:1.2-1.7)。与文盲相比,受过中等教育(aOR = 0.6,95% CI:0.5-0.8)和高等教育(aOR = 0.5,95% CI:0.3-0.8)的成年人的 HCV-Ab 感染率较低;报告输血的成年人的感染率较高(aOR = 1.7,95% CI:1.2-2.4)。与文盲相比,报告输血(aOR = 1.7,95% CI:1.2-2.4)、肝炎家族史(aOR = 2.5,95% CI:1.9-3.3)、过去一年医疗注射(aOR = 2.1,95% CI:1.6-2.7)、纹身(aOR = 1.4,95% CI:1.0-1.9)和传统理发师剃须(aOR = 1.2,95% CI:1.0-1.5)的成年人中,可改变的风险因素占 45%。可改变的风险因素占接触 HCV 的 45%,医疗注射占 38%(95%CI,25.7-48.4%)。信德省的 HCV 感染率在 2007-2019 年间总体呈上升趋势,而 HBV 感染率则有所下降。医疗注射应成为预防活动的重点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Viral Hepatitis
Journal of Viral Hepatitis 医学-病毒学
CiteScore
6.00
自引率
8.00%
发文量
138
审稿时长
1.5 months
期刊介绍: The Journal of Viral Hepatitis publishes reviews, original work (full papers) and short, rapid communications in the area of viral hepatitis. It solicits these articles from epidemiologists, clinicians, pathologists, virologists and specialists in transfusion medicine working in the field, thereby bringing together in a single journal the important issues in this expanding speciality. The Journal of Viral Hepatitis is a monthly journal, publishing reviews, original work (full papers) and short rapid communications in the area of viral hepatitis. It brings together in a single journal important issues in this rapidly expanding speciality including articles from: virologists; epidemiologists; clinicians; pathologists; specialists in transfusion medicine.
期刊最新文献
Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income Countries. Accuracy of International Guidelines in Identifying Normal Liver Histology in Chinese Patients With HBeAg-Positive Chronic HBV Infection. Evolution and Impact of Hepatitis A Epidemiology in Europe-Systematic Literature Review of the Last 20 Years. Minimising Risks in CHB Management Guidelines: A Zero-Risk Approach. Long-Term Follow-Up of Neuropsychiatric Symptoms After Sustained Virological Response to Interferon-Free and Interferon-Based Hepatitis C Virus Treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1